![](/img/cover-not-exists.png)
PP-8-6 Paclitaxel (P) versus doxorublcin (D) as first line chemotherapy (CT) in advanced breast cancer (ABC): A randomized trial with crossover of the EORTC-IDBBC in collaboration with EORTC-ECSG
P. Bruning, M.J. Piccart, J. Klijn, T. Gamucci, Z. Kusenda, J.A. Roy, A. Van Vreckem, R. Paridaens, IDBBCVolume:
32
Year:
1996
Language:
english
DOI:
10.1016/0959-8049(96)84242-0
File:
PDF, 179 KB
english, 1996